Drug Discovery and Development Symposium is organized by Pulmonary Vascular Research Institute (PVRI) and will be held from Jul 10 - 11, 2023 at Bethesda Marriott, Bethesda, Maryland, United States of America.
Description:
The event promises to be an excellent opportunity for regulatory, industry & academic bodies to meet and discuss latest drug developments within pulmonary hypertension.
Featured Topics:
• CDER and CDRH-DCN Initiatives
• FNIH, Pharma and Academia Pioneering of Digital endpoints
• Taking the plunge with actigraphy with USA and China (the water’s warmer than you think)
• Novel trial designs
• FIT-PH/ UK Cohort study- Deciphering the Rosetta stone of digital endpoints
• Stratified and adaptive trial designs
• Bayesian approaches
• Putting the physician in the corner: the patient-centred trial
• PH Group 2 PH Group 3 and Pathophysiology and pathogenesis in adults and paediatric
• Targeting the zinc transporter, ZIP12, with a monoclonal antibody
• Mechanism of action in inhaled therapies - why do they work and how do we design the trials?
• Disruptive technologies in novel drug discovery
• Practical solutions to challenges in drug development
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved